The review article on the basis of recommendations of the European Society of Cardiology and results of clinical and register studies reported at the European Society of Cardiology Congress 2017 discussed difficult issues arising in prescription of anti-thrombotic therapy to patients with acute coronary syndrome, as well as with the concomitant atrial fibrillation; perspective strategies of ischemic and hemorrhagic events risk management are described; results of studies evaluating effectiveness and safety of acute coronary syndrome patients transfer from new antithrombotic agents to clopidrogel are provided
Reprints available through open access at www.westjem.org Objective: To review available evidence an...
The aim was to study the possible protective effect of drug therapy regarding the development of AF ...
International audienceThe management of acute coronary syndrome (ACS) has been at the center of an i...
The management of acute coronary syndrome in Europe is covered by various European Society of Cardio...
Antithrombotic agents are an integral component of the medical regimens and interventional strategie...
The management of acute coronary syndrome in Europe is covered by various European Society of Cardio...
Based on the recommendations of the European Heart Society and the results of clinical and register ...
Timely and effective antithrombotic therapy is critical to improving outcome, including survival, in...
Double anti-platelet therapy (DAPT) comprising a combination of acetylsalicylic acid and one of the ...
Abstract: Antiplatelet and antithrombotic agents significantly alter the clinical course of patients...
The pharmacological treatment strategies for acute coronary syndrome (ACS) in recent years are const...
Acute coronary syndromes: assessing risk and choosing optimal pharmacological regimens for a superio...
The paper presents experience with antithrombotic therapy in a critically ill patient with acute cor...
This is a pre-copyedited, author-produced version of an article accepted for publication in European...
Antiplatelet therapy is integral to the acute and long-term management of acute coronary syndromes (...
Reprints available through open access at www.westjem.org Objective: To review available evidence an...
The aim was to study the possible protective effect of drug therapy regarding the development of AF ...
International audienceThe management of acute coronary syndrome (ACS) has been at the center of an i...
The management of acute coronary syndrome in Europe is covered by various European Society of Cardio...
Antithrombotic agents are an integral component of the medical regimens and interventional strategie...
The management of acute coronary syndrome in Europe is covered by various European Society of Cardio...
Based on the recommendations of the European Heart Society and the results of clinical and register ...
Timely and effective antithrombotic therapy is critical to improving outcome, including survival, in...
Double anti-platelet therapy (DAPT) comprising a combination of acetylsalicylic acid and one of the ...
Abstract: Antiplatelet and antithrombotic agents significantly alter the clinical course of patients...
The pharmacological treatment strategies for acute coronary syndrome (ACS) in recent years are const...
Acute coronary syndromes: assessing risk and choosing optimal pharmacological regimens for a superio...
The paper presents experience with antithrombotic therapy in a critically ill patient with acute cor...
This is a pre-copyedited, author-produced version of an article accepted for publication in European...
Antiplatelet therapy is integral to the acute and long-term management of acute coronary syndromes (...
Reprints available through open access at www.westjem.org Objective: To review available evidence an...
The aim was to study the possible protective effect of drug therapy regarding the development of AF ...
International audienceThe management of acute coronary syndrome (ACS) has been at the center of an i...